1
|
McCauley KE, Durack J, Lynch KV, Fadrosh DW, Fujimura KE, Vundla F, Özçam M, LeBeau P, Caltroni A, Burns P, Tran HT, Bacharier LB, Kattan M, O'Connor GT, Wood RA, Togias A, Boushey HA, Jackson DJ, Gern JE, Lynch SV. Early-life Nasal Microbiota Dynamics Relate to Longitudinal Respiratory Phenotypes in Urban Children. J Allergy Clin Immunol 2024:S0091-6749(24)00195-7. [PMID: 38423369 DOI: 10.1016/j.jaci.2023.12.032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2023] [Revised: 12/05/2023] [Accepted: 12/15/2023] [Indexed: 03/02/2024]
Abstract
BACKGROUND Five distinct respiratory phenotypes based on latent classes of longitudinal patterns of wheezing, allergic sensitization and pulmonary function measured from 0-7 years have been described in urban children. OBJECTIVE To determine whether distinct respiratory phenotypes associate with early-life upper respiratory microbiota development and environmental microbial exposures. METHODS Microbiota profiling was performed using 16S rRNA-based sequencing of nasal samples collected at 12 (n=120) or 36 (n=142) months of age and paired house dust samples collected at 3 months (12-month, N=73; 36-month, N=90) from all four centers in the Urban Environment and Childhood Asthma (URECA) cohort. RESULTS In these high-risk urban children, nasal microbiota increased in diversity between 12 and 36 months of age (ß= 2.04, P=0.006). Age-related changes in microbiota evenness differed significantly by respiratory phenotypes (Interaction P=0.0007) increasing most in the transient-wheeze group. At 12 months of age, respiratory illness (R2=0.055, p=0.0001) and dominant bacterial genus (R2=0.59, p=0.0001) explained variance in nasal microbiota composition and enrichment of Moraxella and Haemophilus members was associated with both transient- and high-wheeze phenotypes. By 36 months, nasal microbiota significantly associated with respiratory phenotypes (R2=0.019, P=0.0376) and Moraxella dominated microbiota associated specifically with atopy-associated respiratory phenotypes. CONCLUSION Nasal microbiota development over the course of early childhood and composition at three years of age associates with longitudinal respiratory phenotypes. These data provide evidence for an early-life window of airway microbiota development that is influenced by environmental microbial exposures in infancy and associated with wheeze- and atopy-associated respiratory phenotypes through 7 years of age.
Collapse
Affiliation(s)
- Kathryn E McCauley
- Department of Medicine, University of California, San Francisco, CA, USA
| | - Juliana Durack
- Department of Medicine, University of California, San Francisco, CA, USA
| | - Kole V Lynch
- Department of Medicine, University of California, San Francisco, CA, USA.
| | - Douglas W Fadrosh
- Department of Medicine, University of California, San Francisco, CA, USA
| | - Kei E Fujimura
- Department of Medicine, University of California, San Francisco, CA, USA
| | - Faith Vundla
- Department of Medicine, University of California, San Francisco, CA, USA
| | - Mustafa Özçam
- Department of Medicine, University of California, San Francisco, CA, USA
| | - Petra LeBeau
- Rho Federal Systems Division Inc., Durham, NC, USA; Now employed at PPD, part of Thermo Fisher Scientific, Wilmington, NC, USA
| | | | | | - Hoang T Tran
- Rho Federal Systems Division Inc., Durham, NC, USA
| | - Leonard B Bacharier
- Division of Allergy, Immunology and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine in St. Louis, St. Louis, MO, USA
| | - Meyer Kattan
- Department of Pediatrics, Columbia University, New York, NY, USA
| | - George T O'Connor
- Department of Medicine, Boston University School of Medicine, Boston, MA, USA
| | - Robert A Wood
- Departments of Pediatrics and Allergy and Immunology, Johns Hopkins University, Baltimore, MD
| | - Alkis Togias
- National Institute of Allergy and Infectious Diseases, Bethesda, MD
| | - Homer A Boushey
- Department of Medicine, University of California, San Francisco, CA, USA
| | - Daniel J Jackson
- Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
| | - James E Gern
- Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
| | - Susan V Lynch
- Department of Medicine, University of California, San Francisco, CA, USA.
| |
Collapse
|